Psychedelic Neuroscience: David Nichols, Ph.D. and Franz Vollenweider, M.D. - Q&A

David Nichols and Franz Vollenweider explore the neuroscientific mechanisms underlying the effects of psychedelic substances. The conversation addresses the pharmacology of LSD in safe clinical settings, differentiating between intravenous and oral administration methods, as well as potential risks like serotonin syndrome. Insights are shared regarding the unique molecular properties of compounds like LSD compared to others. Discussions also touch upon the difficulty of defining the biological basis of consciousness, emphasizing that psychedelic research is moving current scientific understanding closer to grasping these complex phenomena.